| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns a method for treating a proliferative disease associated with PAX/FKHR translocation by introducing N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j[1,7]benzodiazonin-11-yl]-H-methylbenzamide. ^ EFFECT: invention provides high clinical effectiveness. ^ 4 cl, 1 ex |
